Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs
- PMID: 3060616
Pathophysiologic factors affecting the pharmacokinetics of nonsteroidal antiinflammatory drugs
Abstract
The nonsteroidal antiinflammatory drugs are a group of compounds mainly used in the treatment of rheumatologic disorders. Although these agents differ among themselves in their pharmacokinetic properties of absorption, distribution and elimination, they do have some common characteristics, such as high plasma protein binding, small distribution volume, and low plasma clearance. Rheumatoid arthritis, renal and hepatic disease, and old age can potentially affect the disposition of these agents. Unfortunately, no generalizations can be made and, therefore, the effect of these disease states should be carefully studied for each individual agent. A better understanding of the pathophysiologic factors affecting the pharmacokinetics of these agents will improve their efficacy and safety.
Similar articles
-
Effects of perioperative antiinflammatory and immunomodulating therapy on surgical wound healing.Pharmacotherapy. 2005 Nov;25(11):1566-91. doi: 10.1592/phco.2005.25.11.1566. Pharmacotherapy. 2005. PMID: 16232020 Review.
-
[Duration of use of non-steroidal anti-inflammatory agents in patients with rheumatoid arthritis].Rev Rhum Ed Fr. 1994 Dec 15;61(10 Pt 2):165S-172S. Rev Rhum Ed Fr. 1994. PMID: 7858568 Review. French.
-
Disease-induced modifications of drug pharmacokinetics.Int J Clin Pharmacol Res. 1983;3(4):215-26. Int J Clin Pharmacol Res. 1983. PMID: 6381335 Review.
-
Transdermal absorption of nonsteroidal anti-inflammatory drugs in rheumatoid arthritis patients: I. Diclofenac.Int J Clin Pharmacol Ther Toxicol. 1992 Nov;30(11):479. Int J Clin Pharmacol Ther Toxicol. 1992. PMID: 1490791 No abstract available.
-
Non-steroidal anti-inflammatory drugs in domestic animals: II Disposition and clinical indications.J S Afr Vet Assoc. 1995 Mar;66(1):35-41. J S Afr Vet Assoc. 1995. PMID: 7629787
Cited by
-
The problems and pitfalls of NSAID therapy in the elderly (Part II).Drugs Aging. 1991 May;1(3):212-27. doi: 10.2165/00002512-199101030-00005. Drugs Aging. 1991. PMID: 1794015 Review.
-
Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.Drugs Aging. 1996 Dec;9(6):406-17. doi: 10.2165/00002512-199609060-00004. Drugs Aging. 1996. PMID: 8972241 Review.
-
Clinical pharmacokinetics of ibuprofen. The first 30 years.Clin Pharmacokinet. 1998 Feb;34(2):101-54. doi: 10.2165/00003088-199834020-00002. Clin Pharmacokinet. 1998. PMID: 9515184 Review.
-
Clinical pharmacokinetics of tiaprofenic acid and its enantiomers.Clin Pharmacokinet. 1996 Nov;31(5):331-47. doi: 10.2165/00003088-199631050-00002. Clin Pharmacokinet. 1996. PMID: 9118583 Review.
-
Disease-induced variations in plasma protein levels. Implications for drug dosage regimens (Part II).Clin Pharmacokinet. 1990 Sep;19(3):218-29. doi: 10.2165/00003088-199019030-00005. Clin Pharmacokinet. 1990. PMID: 2203581 Review.